Scalper1 News
Veeva Systems (VEEV) is expected to continue its fast growth trajectory in the life science industry when it reports its fiscal Q3 results after the market close on Thursday, its first quarterly report since its successful IPO. The company provides customer relationship management software that helps pharmaceutical and biotech companies better navigate the rigorous process of getting their drugs through clinical trials and the government approval Scalper1 News
Scalper1 News